3Kingston C A, Owens C M, Jeanes A, et al. Imaging of desmoid fibromatosis in pediatric patients[J]. AJR Am J Roentgenol,2002,178( 1 ) : 191-199.
4Tolan S,Sbanks J H,Loh M Y,et al. Fibromatosis:benign by name but not necessarily by nature[J]. Clin Oncol (R-Coll- Radiol ) , 2007,19 ( 5 ) : 319-326.
7Nishino M, Hayakawa K, Minami M, et al. Primary retroperitoneal neoplasms:CT and MR imaging findings with anatomic and pathologic diagnostic clues [ J ]. Radiographics,2003,23 ( 1 ) :45-57.
1Shreyaskwnar R, Harry L, Robert S. Combination chemotherapy in adult desmoid tumors. Cancer, 1993, 72:3244 - 3247.
2Gega M, Yanagi H, Yoshikawa R, et al. Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis. J Clin Oncol, 2006, 24:102 - 105.
3Scott HO, John HE. Combination chemotherapy for desmoid tumors. Cancer, 2003, 97, 1134 - 1135.
4Wehl G, Rossler J, Otten JE, et al. Response of progressive fibromatosis to therapy with liposomal doxorubicin. Onkologie, 2004, 27 : 552 - 556.
5Baliski CR, Temple WJ, Arthur K, et al. Desmoid tumors: a novel approach for local control. J Surg Oncol, 2002, 80:96-99.
6O'Dea F J, Wunder J, Bell RS, et al. Preoperative radiotherapy is effective in the treatment of fibromatosis. Clin Orthop Relat Res, 2003, 415:19 - 24.
8DeWever I, DalCin P, Fletcher CD, et al. Cytogenetic, clinical, and morphologic correlations in 78 cases of fibromatosis : a report from the CHAMP Study Group. Mod Pathol, 2000, 13:1080 - 1085.
9Nuyttens JJ, Rust PF, Thomas CR. Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: a comparative review of 22 articles. Cancer, 2000, 88 : 1517 - 1523.
10Posner MC, Shiu MH, Newsome JL, et al. The desmoid tumor:not a benign disease. Arch Surg, 1989, 124:191 - 196.
2Wang CP, Chang YI.,Ko JY,et al. Desmoid tumor of the head and neckl[J]. Head Neck,2006,28(11):1008 1013.
3Kasper B,Dimitrakopoulou Strauss A, Strauss LG, et al. Posi tron emission tomography in patients with aggressive fibromato- sis/desmoids tumors undergoing therapy with imatinib[J]. Eur J Med Mol Imaging.2010,37(10) :1876 1882.
5Melis M,Zager JS, Sondak VK. Multimodality management of desmoids tumors: how important is a negative surgical margin? [J]. J Surg Oncol,2008,98(8):594-602.
6Mankin HJ, Hornicek FJ, Springfield DS. Extra-abdominal desmoids tumorsa report of 234 cases[J]. J Surg Oneol,2010,102(5) : 380- 384.
7Gluck l,Griffith KA,Biermann S, et al. Role of radiotherapy in the management of desmoids tumors[J]. Int J Radiat Oneol Biol Phys,2011,80(3) :787-792.
8Constantinidou A,Jones RL, Scurr M, et al. Pegylated liposomal doxo- rubicin an effective well-tolerated treatment for refraclory aggressive fi- bromatosis[J]. Eur J Cancer,2009,45(17) :2928-2929.
9Dufresne A,Bertucci F,Penel N,et al. Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis[J]. Br J Cancer,2010,103(4) :482-485.
